Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

706 articles

Showing 1–10 of 10 articles · Keyword: Biomaterials Clear keyword

Advances in pharmacological and pharmaceutical sciences2026ReviewNon-viral Gene DeliveryDrug Delivery

1. From Mucin to Smart Medicine: Engineering Mucin-Based Biomaterials for Advanced and Responsive Drug Delivery

Abudayah Aa

Mucin, a highly glycosylated macromolecular component of mucus, has traditionally been regarded as a biological barrier that restricts drug transport across mucosal surfaces. Growing evidence, however, has repositioned mucin as a functional and engineerable biomaterial with distinctive potential for advanced drug…

Read the article
Drug metabolism and bioanalysis2026ReviewNon-viral Gene DeliveryDrug Delivery

2. Biomaterial-Based Drug Delivery Systems: Bridging Advances and Applications in Regenerative Medicine

Ansari I, Yadav S, Prajapati S

In regenerative medicine, biomaterial-based medication delivery systems are a gamechanger because they allow for the restoration of function and the healing of damaged tissues. This study aims to examine the potential of synthetic and natural biomaterials for the delivery of medications and the regeneration of…

Read the article
Angewandte Chemie International Edition2020ReviewNon-viral Gene Delivery

3. Improving Cancer Immunotherapy Outcomes using Biomaterials

Shuangqian Yan, Zichao Luo, Zhenglin Li, Yu Wang, Jun Tao, Changyang Gong, Xiaogang Liu

Cancer immunotherapy has improved clinical outcomes, but few patients show adequate response rates and long-term responses, and systemic side effects remain common due to the dynamic nature of the immune system. Biomaterial-assisted immunotherapy is a promising approach to improve therapeutic efficacy and reduce side…

Read the article
Acta Biomaterialia (Published by Elsevier Ltd on behalf of Acta Materialia Inc.)2020ResearchNon-viral Gene Delivery

4. Biomimetic Tolerogenic Artificial Antigen Presenting Cells for Regulatory T Cell Induction

Kelly R. Rhodes, Randall A. Meyer, Justin Wang, Stephany Y. Tzeng, Jordan J. Green

Regulatory T cell (Treg)-based therapeutics show promise for treating autoimmune diseases and preventing transplant rejection, but adoptive Treg transfer is expensive, complex, and difficult to implement. "Off-the-shelf" non-cellular alternatives that can induce endogenous Tregs in vivo are needed. Existing…

Read the article
Molecular Therapy2019ReviewNon-viral Gene Delivery

5. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery

Piotr S. Kowalski, Arnab Rudra, Lei Miao, Daniel G. Anderson

mRNA has broad therapeutic potential for vaccination, protein replacement, and gene editing, but its clinical translation is limited by the need for improved intracellular delivery systems. mRNA is much larger than siRNA or ASOs (~300–5,000 kDa, ~1–15 kb vs ~14 kDa and 4–10 kDa, respectively), making delivery more…

Read the article
Nature Reviews Drug Discovery.2019ReviewNon-viral Gene Delivery

6. Delivery Technologies for Cancer Immunotherapy

Rachel S. Riley, Carl H. June, Robert Langer, Michael J. Mitchell.

Immunotherapy has become powerful but broad implementation limited by inability to control immune modulation; serious adverse effects including autoimmunity, nonspecific inflammation. Need delivery technologies to improve efficacy and safety. Numbers.

Read the article
Biomaterials2019ReviewNon-viral Gene Delivery

7. RNA delivery biomaterials for the treatment of genetic and rare diseases

Zhao W, Hou X, Vick Og, Dong Y.

Genetic and rare diseases (GARDs) affect more than 350 million patients worldwide, and many lack effective treatments. RNA-based therapeutics—siRNA, mRNA, miRNA, lncRNA, and RNA-containing genome editing systems—are promising, but naked RNA has poor cellular penetration, is degraded in biological fluids, and does not…

Read the article
2019ReviewNon-viral Gene Delivery

8. Stealth functionalization of biomaterials and nanoparticles by CD47 mimicry

Gheibi Hayat Sm, Bianconi V, Pirro M, Sahebkar A.

Biomaterials and nanoparticles (NPs) used for medical purposes often trigger immune recognition, inflammation, and rapid clearance by the reticuloendothelial system (RES)/mononuclear phagocyte system (MPS). PEGylation and cell-membrane camouflaging are common stealth strategies, but they have limitations, including…

Read the article
Materials2017ReviewNon-viral Gene Delivery

9. Poly(Lactic-co-Glycolic Acid) Applications and Future Prospects for Periodontal Tissue Regeneration

Sun, X.; Wu, G.; Xu, C.; Ye, Q.; Wang, C

Periodontitis causes irreversible destruction of periodontal tissues, and regeneration requires biomaterials with suitable mechanical, degradation, and biological properties. PLGA is attractive for periodontal regeneration because of its biocompatibility, tunable degradation, and processability, but its…

Read the article
Nature2016ReviewNon-viral Gene Delivery

10. Mimicking biological functionality with polymers for biomedical applications

Green, J. J.; Elisseeff, J. H

Biomaterials must increasingly do more than simply avoid rejection; they must actively mimic biological structures and functions to direct cell behaviour, modulate immunity, and repair tissues. This review addresses how biologically inspired polymers can be designed for local tissue engineering, systemic therapeutic…

Read the article
Articles | Brilliant Blue Biosciences